Sam Altman’s Brain Chip Venture Is Mulling Gene Therapy Approach
Sam Altman’s brain-chip venture is exploring the idea of genetically altering brain cells to make better implants. “The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify brain cells,” reports Bloomberg. “In addition, an ultrasound device would be implanted in the head that could
Read More